Anavex Life Sciences Corp (AVXL)

[georgejjl]

Nidan, I agree 100%

This is quite an impressive list of plans for a small company working in a complex environment.
IMO:

Pipeline expansion of the ANAVEX platform using gene biomarkers of response, applying precision medicine for neurological disorders with unmet medical need are expected 2022:

Meeting with FDA for discussing ANAVEX®2-73 Parkinson’s disease program including pivotal Phase 3 study.
Planned initiation of ANAVEX®2-73 imaging-focused Parkinson’s disease clinical study.
Planned initiation of a potentially pivotal Phase 2/3 study in Fragile X Syndrome, the most frequent genetic cause of autism spectrum disorder.
Planned initiation of a Phase 2/3 clinical trial for the treatment of a new rare-disease indication.
Planned initiation of ANAVEX®3-71 Phase 2 clinical trials for FTD, schizophrenias and Alzheimer’s disease indications.

https://ih.advfn.com/stock-market/NASDAQ/anavex-life-sciences-AVXL/stock-news/88059881/anavex-life-sciences-provides-business-update-and

Good luck and GOD bless,